New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.

U.S. Department of Energy Releases Plan to Ensure Free, Immediate, and Equitable Access to Federally Funded Research

The U.S. Department of Energy (DOE) today released a plan to ensure the Department’s Federally funded research is more open and accessible to the public, researchers, and journalists as part of a broader effort by the Biden-Harris Administration to make government data more transparent.

LBBC Spring Patient Experience Newsletter: Equity and Financial Toxicity

While Keneene Lewis of Atlanta was undergoing chemotherapy in 2019, bill collectors were calling her home. Today, she encourages those she meets to speak up and advocate for themselves. Plus, new FDA guidance on the risk factors of dense breasts, and the petition demanding equitable access to DIEP flap breast reconstruction.